Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

JP Morgan Maintains Overweight on Brunswick, Raises Price Target to $113

JP Morgan analyst Matthew Boss maintains Brunswick (NYSE:BC) with a Overweight and raises the price target from $106 to $113.

byBenzinga Newsdesk

June 18, 2021

1 minute read

JP Morgan analyst Matthew Boss maintains Brunswick (NYSE:BC) with a Overweight and raises the price target from $106 to $113.

Lennox Q1 Earnings Beat Estimates; Margin Contracts On Supply Chain Woes

By Shivani Kumaresan

April 25, 8:58 AM

Lennox International Inc (NYSE:LII) reported first-quarter FY22 revenue growth of 9% year-on-year to $1.01 billion, beating the consensus of $961.61 million.…

LII

Piper Sandler Initiates Coverage On Enovix with Overweight Rating, Announces Price Target of $39

By Benzinga Newsdesk

December 17, 7:15 AM

Piper Sandler analyst Greg Tuttle initiates coverage on Enovix (NASDAQ:ENVX) with a Overweight rating and announces Price Target of $39.

ENVX

UK Sunday Times Reported Russia is Paving the Way for a Takeover of Moldova

By Charles Gross

May 1, 6:27 PM

https://www.thetimes.co.uk/article/russia-is-already-paving-the-way-for-a-takeover-of-moldova-hl9zg3v7b

RSX

Mustang Bio’s Gene Therapy For Genetic Immunodeficiency Receives European PRIME Tag

By Vandana Singh

August 2, 10:31 AM

The European Medicines Agency has granted Priority Medicines designation to Mustang Bio Inc’s (NASDAQ:MBIO) MB-107 for X-linked severe combined immunodeficiency (X-SCID) in…

MBIO

JP Morgan Maintains Overweight on Brunswick, Raises Price Target to $113

Related Posts

Lennox Q1 Earnings Beat Estimates; Margin Contracts On Supply Chain Woes

Piper Sandler Initiates Coverage On Enovix with Overweight Rating, Announces Price Target of $39

UK Sunday Times Reported Russia is Paving the Way for a Takeover of Moldova

Mustang Bio’s Gene Therapy For Genetic Immunodeficiency Receives European PRIME Tag